Theravance Biopharma Inc. (TBPH)

TBPH trades at $13.14, 31.4% above the near-term max pain of $10 expiring Aug 15, 2025 (0 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($2.5-$12.5), signaling increased put positioning or downside protection. Key magnetic zone at 10 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for TBPH shows a downward trend from 12.5 to 2.5, indicating bearish sentiment or hedging activity. The 111% spread signals divergent expectations across timeframes. Most levels below 13.14 may cap rallies. Strong magnetic level at 10 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.